CD274 and non-small cell lung carcinoma: In the case of smokers and NSCLC stage, only current/former smokers (HRpooled = 0.623, 95% CI: 0.47–0.83, p = 0.001) benefited from single PD-(L)1 monotherapy over chemotherapy.